Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. - Wikidata - wikimedia - TriplyDB

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

http://www.wikidata.org/entity/Q40401116

about

Year in review 2015: Asthma and chronic obstructive pulmonary disease Paving the way of systems biology and precision medicine in allergic diseases: the MeDALL success story: Mechanisms of the Development of ALLergy; EU FP7-CP-IP; Project No: 261357; 2010-2015.Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice.Use of electronic medical records and biomarkers to manage risk and resource efficiencies Burden of asthma with elevated blood eosinophil levels.Value of peripheral blood eosinophil markers to predict severity of asthma Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy.Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma.Targeted Therapy for Older Patients with Uncontrolled Severe Asthma: Current and Future Prospects.Phenotype-Driven Therapeutics in Severe Asthma.Asthma Exacerbations: Pathogenesis, Prevention, and Treatment.The Biology of Eosinophils and Their Role in Asthma.Asthma biomarkers in the age of biologics.Pharmacokinetic drug evaluation of mepolizumab for the treatment of severe asthma associated with persistent eosinophilic inflammation in adults.Differential effects of obesity on eosinophilic vs. non-eosinophilic asthma subtypes.Predictive Biomarkers for Asthma Therapy.Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population.Does FeNO Predict Clinical Characteristics in Chronic Cough?Blood eosinophils: The forgotten man of inhaled steroid dose titration.High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history.Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data.Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland.Eosinophilia as a treatable trait in three patients with asthma and COPD.Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study Involvement and Possible Role of Eosinophils in Asthma Exacerbation Anti-IL-5 therapy in patients with severe eosinophilic asthma - clinical efficacy and possible criteria for treatment response What Does the TOVITO Programme Tell Us about How We Can Manage COPD?

P2860

Q26749314-22E6D7A8-7F6A-493E-A275-38D0F1825C0E Q30251797-4EDF2D61-3ACF-4209-A38F-8E3E7E784836 Q30276073-31F971C6-4E5A-4148-9844-D9DF7B5D99E3 Q31038671-DCE3B154-1A4E-4666-A186-F632F88C9F15 Q33602020-DA36E6D3-39D4-40AE-860D-1504B828E84E Q36076733-31D100A6-D7EA-486D-91B3-0D9B15C5A2B9 Q36090466-D3289737-2742-4C6D-8F82-E2FB0AA0055E Q38606180-026C7AF0-A112-45FC-8D8F-3466EB3364D3 Q38609480-9EE62BB9-FA42-44EF-877D-360AC18486AB Q38820261-E3F91039-21D7-469A-908B-0F3392204BC0 Q39148802-359F0C77-0605-4BB8-A525-ECB33BF52E40 Q39423972-6B9F6AE2-3D64-48FC-99B3-CDF73BD9A5C2 Q39438308-233B7751-1676-4E91-BAF1-C49369D8A503 Q47169950-605FDC18-9E33-4B13-AECC-9B3458C0565C Q47383058-52ED9371-3BE2-49BE-9BC3-7520DF670A77 Q47657803-A4D00637-79BD-4309-99FF-6DD15EC3B8D5 Q47683405-CFB4BFF0-8376-4366-B3DE-22F3E44F7F4F Q47691413-11618BC3-F940-4CFC-B9E1-B56E57485867 Q47699175-F64921FD-865B-45B0-9166-18EB4E693C2D Q47718368-53CA5DDC-5852-4B91-B2CB-CD80EB6E40D4 Q50558071-70599BFF-FF1A-4CDC-9A6B-5587E7C7FAAB Q52584472-B24D5F89-11BE-4E60-8F80-E406D741CF07 Q55005928-7EB3AAE8-F018-4EE9-A315-02AF2B2934E9 Q55082118-761FBA70-4F84-4A96-B79D-3957DBF3898F Q55363585-7BEE9FD1-7C07-49D7-A97E-7E4F41039970 Q55370774-760B3E43-8CD7-470B-8988-E91819370FAB Q57175093-0207A928-2056-490D-B21C-CA57BF4435A7 Q57490103-BAC77B30-47DC-4B1D-AD27-7F52D4B2BFC0 Q58816356-7F312E47-BF15-4CA8-A799-6D82E6111162 Q59131559-D9520FBF-5427-4C0F-8816-CDDD5B32B6FF

P2860

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

http://www.wikidata.org/entity/Q40401116

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

@en

type

label

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

@en

prefLabel

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

@en

P1433

Q40401116-B0DDDC1B-274E-49A7-8C67-CF232F9957DA

P1476

Q40401116-66F57CC1-9EC2-4147-B513-E763A7FDB0F9

P2093

Q40401116-09657A91-D45F-4D6C-87C8-9ED0C5C01C31

Q40401116-1BA3A50B-31C3-4C29-92CC-BD13B5C71C06

Q40401116-2EDD829D-6D96-46CA-83BE-4BAE13027920

Q40401116-4342DD10-CF4D-44CE-BF7B-2FBBBB5D11AF

Q40401116-4B561DE7-61BC-48A4-BA73-B6DFC112FCC0

Q40401116-77A407C5-6B23-431E-9C82-CB2EB0CD9009

Q40401116-92F8BF81-C617-49CC-93BC-0C360D2B479C

Q40401116-A1771A69-17ED-4392-8888-54A7D5B134F9

Q40401116-AE7E95B6-1E97-4850-AAC3-D27290A00A01

Q40401116-D344F8B2-C56A-440D-940F-2941EB963BD6

P304

Q40401116-35F05391-9852-41B3-B662-C5C0826AB105

P31

Q40401116-EC7CFA1D-1636-4DFC-8E52-069E2F69DF3F

P356

Q40401116-E6A5B696-BBBE-4E40-ADC4-00E8FD0A1F22

P433

Q40401116-0A041E66-E762-455B-A002-BA2EDC3B176D

P478

Q40401116-3F45F80A-F3AC-42D6-AD5A-D4F659EB5E9E

P50

Q40401116-38435D63-8C51-41AC-A051-8FD2A546E1B1

Q40401116-EC60EF32-7DA0-4162-BDB7-21CC4B0F066F

P577

Q40401116-16394C03-31C3-4770-98A0-650CFE0661CB

P698

Q40401116-56784C7A-9A17-478E-93BB-258B18ACC24B

P356

S2213-2600(15)00367-7

P1433

The Lancet. Respiratory medicine

P1476

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.

@en

P2093

Andrew M Wilson

http://www.w3.org/2001/XMLSchema#string

Anna Rigazio

http://www.w3.org/2001/XMLSchema#string

Anne Burden

http://www.w3.org/2001/XMLSchema#string

Christopher J Corrigan

http://www.w3.org/2001/XMLSchema#string

David B Price

http://www.w3.org/2001/XMLSchema#string

Elizabeth V Hillyer

http://www.w3.org/2001/XMLSchema#string

Gokul Gopalan

http://www.w3.org/2001/XMLSchema#string

Jonathan D Campbell

http://www.w3.org/2001/XMLSchema#string

Marjan Kerkhof

http://www.w3.org/2001/XMLSchema#string

Mary Buatti Small

http://www.w3.org/2001/XMLSchema#string

P304

849-858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S2213-2600(15)00367-7

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Eugene R Bleecker

P577

2015-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26493938

http://www.w3.org/2001/XMLSchema#string